Danish pharma company on cusp of international success

Diabetes drug could be headed to the US

Danish pharmaceutical company Danske Zealand Pharma has taken a major step in capitalising on its diabetes product Lyxumia.

The Glostrup-based firm and its partner Sanofi has received approval for a US application for the composite product Lixilan.

Lixilan is a mixture of Danske Zealand Pharma’s Lyxumia and the world’s best-selling insulin, Lantus Sanofios.

Now that the application has been officially processed, the company will find out in August if its product has been approved.

“The US approval of the application is an important milestone in the regulatory process for this new type of diabetes drug,” said Danske Zealand Pharma head Britt Meelby Jensen.

Profitable combination
Lyxumia is a GLP-1 analog that acts by stimulating the pancreatic production of insulin. It is the same type of product as Novo Nordisk’s Victoza, which earned 18 billion kroner in 2015.

Lyxumia as a single agent earned Dansk Zealand Pharma 21 million kroner in royalties in the first nine months of 2015.

READ MORE: Danish diabetes treatment among the best in Europe

The combination product Lixilan could help to considerably increase sales of Lyxumia.





  • A human touch can keep Europe’s elderly in the labor market

    A human touch can keep Europe’s elderly in the labor market

    In many European countries, the older generations are on the verge of retirement. In Northern Europe, companies and organizations are better than elsewhere in Europe at getting seniors to work after retirement age. Some simple tools seem to work

  • Copenhagen ranked 4th for career growth

    Copenhagen ranked 4th for career growth

    Copenhagen is ranked as the fourth-best city in the world for career growth, according to an analysis by EnjoyTravel. This ranking considers various factors such as living costs, salary levels, workforce availability, and overall quality of life. Copenhagen is noted for its blend of historical and modern elements, particularly in the green energy sector, which influences job opportunities.

  • Data shows that non-Western immigrants have saved local economies in Denmark

    Data shows that non-Western immigrants have saved local economies in Denmark

    A study reveals how only the massive influx of non-Western immigrants has saved many areas in Denmark from a decline in the workforce and a consequently shrinking economy